Xconomy: OrbiMed Advisors News, Articles and Opinions

“orbimed-advisors” Archives

Entry	Author	Date	Location
SpringWorks, Armed with Ex-Pfizer Cancer Drugs, Reloads with $125M	Ben Fidler	04/01/19	New York
Turning Point Therapeutics Plans IPO to Advance Targeted Cancer Drugs	Sarah de Crescenzo	03/22/19	San Diego
Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again	Ben Fidler	02/14/19	National
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More	Frank Vinluan	10/26/18	National
TP Therapeutics Names New CEO, Gets $80M More for Cancer Drug Push	Sarah de Crescenzo	10/19/18	San Diego
Bio Roundup: IDO Fallout, Express Scripts Dumps Amgen, Isaly Out & More	Ben Fidler	05/04/18	National
OrbiMed Founder Isaly Steps Down After Sexual Harassment Report	Corie Lok	12/08/17	New York
Report: Sexual Harassment Claims Hit OrbiMed Founder Sam Isaly	David Holley	12/06/17	New York
SpringWorks Spins Out of Pfizer With $103M to Give Shelved Drugs New Life	Ben Fidler	09/25/17	New York
Bio Roundup: $1B Deals, Data Bumps, Acorda’s Lumps, Generic OKs & More	Alex Lash	08/11/17	National
For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY	Ben Fidler	08/09/17	New York
Not Resting on Hemophilia Biz, Bioverativ Pays $400M For True North	Ben Fidler	05/23/17	Boston
Gates Foundation Leads $45.5M Round for Gerngross’s Biotech Arsanis	David Holley	04/26/17	Boston
Ex-Dendreon CEO, Gold, Returns to Wall Street as Alpine, Nivalis Merge	Ben Fidler	04/18/17	Seattle
Aiming At P53, Cancer’s Hard Target, PMV Pharma Raises $74M	Ben Fidler	02/22/17	New York
Cleave Bio Gets $37M From Celgene, Others For Clinical Push	David Holley	08/08/16	San Francisco
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval	Ben Fidler	07/20/16	San Francisco
Retooled Selecta Bio Takes Crossover Cash to IPO Queue	Ben Fidler	05/24/16	Boston
West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More	Bruce V. Bigelow	01/29/16	San Diego
Adicet Joins the Immunotherapy Fray With $51M and Mystery Cells	Alex Lash	01/27/16	San Francisco
Exosome Diagnostics Closes $60M Series B for Liquid Biopsy Test	David Holley	01/07/16	Boston
With $100M, Guardant Health to Expand Reach of Blood Test for Cancer	David Holley	01/07/16	San Francisco
Bristol-Myers to Add Cardioxyl’s Heart Failure Drug With $300M Deal	Frank Vinluan	11/02/15	Raleigh Durham
Alector Raises $32M For Immune-Based Neuro Drug Development	Alex Lash	09/16/15	San Francisco
Avitide Gets $7.6M More to Purify Complex Biologics	Ben Fidler	08/06/15	Boston
Gene Therapy Upstart Dimension Nabs $65M From “Crossover” Backers	Ben Fidler	04/21/15	Boston
Pop That Bubble: 5 Reasons Biotech Needs A Different Metaphor	Alex Lash	04/14/15	National
West Coast Biotech Roundup: Juno, Tekmira, True North, aTyr & More	Alex Lash	04/10/15	Seattle
With $35M Infusion, True North Moves Rare Disease Drug Into Clinic	Alex Lash	04/07/15	San Francisco
Prenatal Screener Natera Grabs $55M, Considers Cancer Test	David Holley	04/06/15	San Francisco
Page 1 of 6	next page »